Regulatory · source year
4 selected, source-linked regulatory records dated 2007. This is selective source coverage, not a complete timeline.
4 selected records.
2 connected profiles.
4 distinct public records.
Cited chronology
Lanreotide
The official Drugs@FDA dataset lists original submission 1 for NDA 022074 with status AP dated 2007-08-30, and names lanreotide acetate among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Octreotide
The official Drugs@FDA dataset lists original submission 1 for ANDA 077372 with status AP dated 2007-08-14, and names octreotide acetate among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Octreotide
The official Drugs@FDA dataset lists original submission 1 for ANDA 077373 with status AP dated 2007-08-14, and names octreotide acetate among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Octreotide
The Federal Register published notice E7-4877, attributed to FDA and its parent HHS department, on 2007-03-19. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.
Source: Federal Register via GovInfo ↗